<DOC>
	<DOC>NCT00703482</DOC>
	<brief_summary>The purpose of this study was to study the effect of different combinations of fenofibrate and coenzyme Q10 on ventricular diastolic function in patients with Type II diabetes</brief_summary>
	<brief_title>A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Men or women aged from 40 to 79 years Patients with preexisting T2DM HbA1C &lt;9% Written informed consent unable to comply with the protocol, Likely to leave the trial before completion having participated in an another trial 3Ã  days before V1 Pregnant or childbearing potential not using birth control method Type 1 diabetic patients, T2Dm insulin therapy Patients with one of the following pathology: with muscular disorders known or increase CK , or hepatic deficiency or transaminase increase with symptomatic gallbladder disease or/and renal insufficiency with abnormal thyroid function with proliferative retinopathy with recent cardiovascular event, uncontrolled hypertension with known chronic alcohol intake with other severe pathology with TC&gt;= 7.0 mmol/L and/or TG&gt;= 4mmol/L at V1 Patients treated with Warfarin Patients with specific ECG dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Ventricular diastolic Function</keyword>
	<keyword>Diabetes</keyword>
</DOC>